Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
Recruiting · NCT07476001 · Registry updated 2026-05-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC | Metastatic Castration-resistant Prostate Cancer | Recruiting | Phase 2 | 2026-05-15 | NCT07476001 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 162 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Moffitt Cancer Center | Tampa | United States | 523 |